Future Virology Ahead of Print | normal
Step-down strategy in antiviral resistant chronic hepatitis B patients who achieved viral suppression with rescue combination therapy
Dong Yun Kim
& Jun Yong Park
Published Online: 10 Sep 2018 https://doi.org/10.2217/fvl-2018-0078
Tools
Share
Abstract
In the treatment of chronic hepatitis B (CHB) patients with drug resistance, rescue combination therapy leads to viral suppression in almost all patients. However, once it is achieved, lifelong maintenance especially, by using combination therapy is not always possible in a significant proportion of patients. At present, there is no consensus on whether it is possible to switch to monotherapy from combination therapy. However, there is robust evidence to support step-down therapy, which involves switching from combination therapy to monotherapy in antiviral resistant CHB patients who achieve complete viral response from combination therapy. We review the evidence in favor of switching to monotherapy in antiviral resistant CHB patients who achieve complete viral response by combination therapy.
Keywords:
chronic hepatitis B combination therapy drug resistant hepatitis b virus step-down therapy
Dong Yun Kim Jun Yong Park
Authors and Affiliations
Dong Yun Kim 1
Jun Yong Park * ,1 ,2 ,3
1. Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea
2. Institute of Gastroenterology, Yonsei University College of Medicine, Seoul, Korea
3. Yonsei Liver Center, Severance Hospital, Seoul, Korea